Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases
Omicron变异株的优势地位和抗SARS-CoV-2疫苗接种是系统性自身免疫性风湿病患者COVID-19病情较轻的关键决定因素。
期刊:Clinical Rheumatology
影响因子:2.8
doi:10.1007/s10067-023-06769-4
Papagoras, Charalampos; Zioga, Nikoleta; Papadopoulos, Vasileios; Gerolymatou, Nafsika; Kalavri, Eleni; Bounos, Christos; Simopoulou, Theodora; Fragoulis, George E; Panopoulos, Stylianos; Fragiadaki, Kalliopi; Evangelatos, Gerasimos; Bournia, Vasiliki-Kalliopi; Arida, Aikaterini; Karamanakos, Anastasios; Pappa, Maria; Kravvariti, Evrydiki; Deftereou, Kleopatra; Kougkas, Nikolaos; Zampeli, Evangelia; Kataxaki, Evangelia; Melissaropoulos, Konstantinos; Barouta, Georgia; Panagiotopoulos, Alexandros; Koutsianas, Christos; Liossis, Stamatis-Nick; Georgiou, Panagiotis; Dimitroulas, Theodoros; Tektonidou, Maria G; Bogdanos, Dimitrios P; Elezoglou, Antonia; Voulgari, Paraskevi V; Sfikakis, Petros P; Vassilopoulos, Dimitrios